StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > baaasterds

<< Previous

Bullboard Posts

Next >>

Comment by Str8Shuteron Feb 17, 2021 11:36am

108 Views

Post# 32584737

RE:baaasterds

Well, you're good to go now after someone hit that 9 cent bid hard.

The good news is that the WT warrants still represent excellent value (i.e. risk/reward attributes) even at the current Ask of $0.095, since that includes around one penny of time value with 28 months remaining before expiry. I think that these price levels are going to seem crazy cheap when looking back in a few months. GLTA!